Lv3
210 积分 2025-11-04 加入
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
1个月前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1个月前
已完结
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
1个月前
已完结
POS0214 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2/3 STUDY OF SHR0302, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS
1个月前
已关闭
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point
1个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2个月前
已完结
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
3个月前
已完结
Aldosterone Synthase Inhibition for Hypertension
3个月前
已完结
Current trends and advances in the management of acquired Hemophilia A
8个月前
已完结
皖公网安备34019202002308
